Showing results (1811-1820 of 1,877) with videos related to
Sort By:
Pageof 188
Journal of Clinical Medicine|May 14, 2022
Gardnerella vaginalis in Recurrent Urinary Tract Infection Is Associated with Dysbiosis of the Bladder MicrobiomeJeong-Ju Yoo, Ju Sun Song, Woong Bin Kim, et al.Cancer Communications (London, England)|October 18, 2019
Phase II study of R-CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) studySung Yong Oh, Won Seog Kim, Jin Seok Kim, et al.Leukemia & Lymphoma|June 26, 2020
Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysisGa-Young Song, Sung-Hoon Jung, Je-Jung Lee, et al.Leukemia & Lymphoma|April 10, 2008
Prognostic implications of the immunophenotype in biphenotypic acute leukemiaJe-Hwan Lee, Yoo Hong Min, Chul Won Chung, et al.Annals of Hematology|February 25, 2010
Phase IV study evaluating efficacy of escalated dose of imatinib in chronic myeloid leukemia patients showing suboptimal response to standard dose imatinibYoungil Koh, Inho Kim, Sung-Soo Yoon, et al.Plos One|March 9, 2018
Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical featuresKee Hong Park, Patrick Waters, Mark Woodhall, et al.Haematologica|July 3, 2025
Serial next-generation sequencing for detecting germline predisposition in acute myeloid leukemiaJae-Sook Ahn, Joo Heon Park, ChangSun Lee, et al.Annals of Hematology|April 6, 2013
Escalated daunorubicin dosing as an induction treatment for Philadelphia-negative adult acute lymphoblastic leukemiaSang Min Lee, Won Sik Lee, Ho Jin Shin, et al.Oncotarget|April 19, 2017
Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancerHyo Song Kim, Hanna Lee, Su-Jin Shin, et al.Journal of Hematology & Oncology|August 15, 2012
Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)Yu Ri Kim, Jin Seok Kim, Yoo Hong Min, et al.Pageof 188